Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | No | No |
| Is net profit margin increasing? | Yes | No |
| Is asset turnover increasing? | Yes | No |
| Is equity multiplier increasing? | Yes | No |
| Competitors Used |
|---|
| Jourdeness Group Limited |
| Natural Beauty Bio-Technology Limited |
| Microbio Co., Ltd. |
| Sagittarius Life Science Corp |
| Maywufa Company Ltd. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| 4,190 | 157 | 4,128 | 3,205 | 1,731 | 4,137 | |||
| Return On Equity | ||||||||
| Latest Twelve Months | -15% | -20% | -10% | -11% | 8% | 9% | ||
| Fiscal Year - 1 | 0% | -3% | -10% | -12% | 8% | 21% | ||
| Fiscal Year - 2 | 1% | -5% | 2% | -15% | 8% | 14% | ||
| Fiscal Year - 3 | 13% | 6% | 0% | -16% | 8% | 29% | ||
| Fiscal Year - 4 | 13% | 1% | 8% | -12% | 9% | 22% | ||
| Fiscal Year - 5 | 24% | 4% | -3% | -16% | 6% | 34% | ||
| Average | 6% | -3% | -2% | -14% | 8% | 21% | ||
| Median | 7% | -1% | -1% | -14% | 8% | 21% | ||
| Benchmarks | Ticker | |||||||
| Jourdeness Group Limited | TWSE:4190 | |||||||
| Natural Beauty Bio-Technology Limited | SEHK:157 | |||||||
| Microbio Co., Ltd. | TPEX:4128 | |||||||
| Sagittarius Life Science Corp | TPEX:3205 | |||||||
| Maywufa Company Ltd. | TWSE:1731 | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | Jun-11 | Jun-00 | Apr-11 | Oct-08 | Sep-04 | Apr-11 | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 2,281 | 354 | 1,723 | 468 | 1,486 | 4,067 | ||
| Fiscal Year | 2,281 | 354 | 1,723 | 468 | 1,486 | 4,067 | ||
| Fiscal Year - 1 | 2,976 | 336 | 1,591 | 440 | 1,301 | 4,535 | ||
| Fiscal Year - 2 | 2,778 | 336 | 1,722 | 529 | 1,245 | 4,069 | ||
| Fiscal Year - 3 | 2,819 | 488 | 1,782 | 588 | 1,289 | 5,271 | ||
| Fiscal Year - 4 | 2,731 | 411 | 1,601 | 558 | 1,065 | 4,056 | ||
| Fiscal Year - 5 | 3,252 | 438 | 1,466 | 439 | 1,101 | 5,139 | ||
| Net Income | ||||||||
| Latest Twelve Months | (292) | (104) | (1,101) | (49) | 173 | 473 | ||
| Fiscal Year | (292) | (104) | (1,101) | (49) | 173 | 473 | ||
| Fiscal Year - 1 | (0) | (15) | (1,180) | (55) | 169 | 1,034 | ||
| Fiscal Year - 2 | 14 | (30) | 211 | (74) | 162 | 690 | ||
| Fiscal Year - 3 | 292 | 35 | 49 | (86) | 164 | 1,355 | ||
| Fiscal Year - 4 | 258 | 8 | 664 | (74) | 171 | 960 | ||
| Fiscal Year - 5 | 470 | 22 | (234) | (120) | 101 | 1,432 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 7,856 | 872 | 14,735 | 665 | 2,832 | 8,905 | ||
| Latest Fiscal Quarter | 7,389 | 773 | 13,927 | 520 | 3,178 | 8,893 | ||
| Fiscal Year | 7,389 | 773 | 13,927 | 520 | 3,178 | 8,893 | ||
| Fiscal Year - 1 | 7,856 | 872 | 14,735 | 665 | 2,832 | 8,905 | ||
| Fiscal Year - 2 | 8,186 | 872 | 15,091 | 579 | 2,530 | 8,677 | ||
| Fiscal Year - 3 | 8,440 | 930 | 15,017 | 676 | 2,692 | 10,035 | ||
| Fiscal Year - 4 | 7,030 | 832 | 13,926 | 741 | 2,476 | 8,964 | ||
| Fiscal Year - 5 | 6,470 | 757 | 10,052 | 812 | 2,735 | 8,154 | ||
| Fiscal Year - 6 | 5,999 | 679 | 10,233 | 894 | 2,673 | 6,388 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 2,078 | 575 | 11,811 | 515 | 2,037 | 5,149 | ||
| Latest Fiscal Quarter | 1,770 | 448 | 10,306 | 408 | 2,107 | 5,544 | ||
| Fiscal Year | 1,770 | 448 | 10,306 | 408 | 2,107 | 5,544 | ||
| Fiscal Year - 1 | 2,078 | 575 | 11,811 | 515 | 2,037 | 5,149 | ||
| Fiscal Year - 2 | 2,157 | 597 | 12,093 | 442 | 1,997 | 4,653 | ||
| Fiscal Year - 3 | 2,281 | 658 | 11,894 | 517 | 2,006 | 4,993 | ||
| Fiscal Year - 4 | 2,072 | 611 | 10,628 | 586 | 1,876 | 4,408 | ||
| Fiscal Year - 5 | 2,021 | 568 | 6,710 | 674 | 1,757 | 4,382 | ||
| Fiscal Year - 6 | 1,863 | 552 | 7,331 | 797 | 1,719 | 4,114 | ||